Stories

A new synthetic nicotine, Metatine, similar to traditional nicotine, has entered the U.S. vaping market, evading FDA regulations. Concerns arise as studies suggest it may be more potent and harmful than nicotine. Researchers worry about mislabeling and lack of data on its effects when burned or metabolized. Calls for regulatory action urge caution due to potential risks and loopholes in current laws. Experts emphasize the need for thorough scientific evidence to ensure public health protection. The FDA is funding research on nicotine analogs but acknowledges a lack of comprehensive data. Authorities face challenges in defining and regulating these emerging products amid growing concerns.

Ireland plans to ban disposable vapes sales with restrictions on colors and imagery to prevent targeting youth. Concerns over environmental impact and nicotine levels have prompted the new measures. The ban will build on existing regulations prohibiting sales to those under 18 and aims to address the issue of vapes potentially leading to smoking. The Minister of State for Public Health emphasized the need for changes in selling nicotine products and indicated upcoming rules on flavored vapes. Ireland joins other European countries in responding to the growing use of such products, reminiscent of past actions like the smoking ban.

Brian King, head of the FDA's Center for Tobacco Control, faces a House hearing due to agency failures and political influence. The CTP's mishandling led to court criticism and whistleblower claims of neglecting science for politics. Amid demands for FDA reform, the agency's delays in approving safer nicotine products endanger public health. Transparency issues, administrative burdens, and public misperceptions on vaping worsen the situation. The hearing seeks accountability and urges the FDA to prioritize harm-reducing products, highlighting the need for structural reforms to protect millions of lives.

The FDA regulates ENDS and vaping products under federal tobacco legislation, treating them like cigarettes. Restrictions on providing truthful information hinder public health efforts, limiting consumers' knowledge about product risks. While ENDS are less harmful than cigarettes, regulations prevent producers from educating consumers. Misunderstandings about tobacco product risks persist, impacting public health negatively. Current restrictions on speech regarding product risks may not align with health promotion goals and raise First Amendment concerns. Recognizing and protecting ENDS producers' speech rights could enhance public health outcomes. [...]

Over the last six months I’ve been using nicotine pouches to try to get away from cigarettes. I’ve managed to go from smoking as many as 16 cigarettes a day to just one or two, all because of nicotine pouches. I am sure other people have experienced similar benefits from pouches. Unfortunately, federal Health Minister Mark Holland has decided to seriously restrict access to pouches, which is going to make it harder for thousands of people like me to quit. In the name of protecting kids from nicotine pouches, Ottawa has decided to limit the flavours available to just mint or menthol and ban the fruit flavours that were previously legal and approved by Health Canada.

Disposable vapes with lithium batteries are leading to significant environmental damage. In the UK, around five million vapes are discarded weekly, with only 17% recycled. The use of lithium batteries in disposable vapes is wasteful and poses dangers in disposal. The ban on disposable vapes in Ireland by 2024 reflects growing concerns. These vapes use lithium batteries for high power density but are challenging to recycle. Improper disposal can lead to fires and toxic emissions. Reconsidering the use of single-use electronics is crucial to lessen the environmental impact and address the waste issue.

Representatives of the U.S. vapor industry had mixed feelings on the fourth anniversary of PMTA filings. The FDA has received 26 million applications for novel tobacco products, mostly e-cigarettes, but rejected over 99% of them. The agency approved over 6,000 new combustible tobacco products while only allowing four vaping devices as cigarette alternatives. The refusal to authorize flavored e-cigarettes aimed to protect youth, despite a decline in youth vaping rates. The vapor industry criticized the FDA for prioritizing deadly combustible products, leading to millions of smoking-related deaths and substantial healthcare costs.

The Czech Republic plans to ban flavored vapes, except tobacco, next year. This move, coupled with a new tax, has sparked criticism from vape industry leaders, who argue that the ban could hinder smoking cessation efforts. Studies show flavored vapes help smokers quit, making the ban counterproductive. The government's decision also contradicts its previous support for vaping as a smoking cessation tool. Critics warn the ban may lead ex-smokers to revert to conventional cigarettes or turn to the black market. Advocates suggest focusing on limiting vape access to minors instead of implementing a blanket ban on flavors. Similarly, the UK is considering similar restrictions on flavored vapes to deter youth vaping.

The latest U.S. vaping statistics show increasing popularity in vaping and decreasing smoking rates, highlighting the need for updated FDA regulations. Despite the rise in vaping, restrictions hinder access to safer smoking alternatives. SAMHSA reports an increase in adult vaping and a decrease in cigarette use. Tobacco manufacturers face declining sales due to economic pressures and rising disposable e-cigarette products. Current regulatory processes favor major tobacco companies, limiting market competition. The FDA's slow approval of safer alternatives poses challenges, overlooking the growing adult vaping market. Congressional intervention is crucial to amend outdated tobacco laws and improve access to harm reduction products for American adults.